224 related articles for article (PubMed ID: 17575049)
41. Small-molecule inhibitors targeting G-protein-coupled Rho guanine nucleotide exchange factors.
Shang X; Marchioni F; Evelyn CR; Sipes N; Zhou X; Seibel W; Wortman M; Zheng Y
Proc Natl Acad Sci U S A; 2013 Feb; 110(8):3155-60. PubMed ID: 23382194
[TBL] [Abstract][Full Text] [Related]
42. Interaction between the type III effector VopO and GEF-H1 activates the RhoA-ROCK pathway.
Hiyoshi H; Okada R; Matsuda S; Gotoh K; Akeda Y; Iida T; Kodama T
PLoS Pathog; 2015 Mar; 11(3):e1004694. PubMed ID: 25738744
[TBL] [Abstract][Full Text] [Related]
43. ROCK1 feedback regulation of the upstream small GTPase RhoA.
Tang AT; Campbell WB; Nithipatikom K
Cell Signal; 2012 Jul; 24(7):1375-80. PubMed ID: 22430126
[TBL] [Abstract][Full Text] [Related]
44. Regulation of cell polarity and protrusion formation by targeting RhoA for degradation.
Wang HR; Zhang Y; Ozdamar B; Ogunjimi AA; Alexandrova E; Thomsen GH; Wrana JL
Science; 2003 Dec; 302(5651):1775-9. PubMed ID: 14657501
[TBL] [Abstract][Full Text] [Related]
45. ArhGEF18 regulates RhoA-Rock2 signaling to maintain neuro-epithelial apico-basal polarity and proliferation.
Herder C; Swiercz JM; Müller C; Peravali R; Quiring R; Offermanns S; Wittbrodt J; Loosli F
Development; 2013 Jul; 140(13):2787-97. PubMed ID: 23698346
[TBL] [Abstract][Full Text] [Related]
46. Breast cancer antiestrogen resistance 3 (BCAR3) promotes cell motility by regulating actin cytoskeletal and adhesion remodeling in invasive breast cancer cells.
Wilson AL; Schrecengost RS; Guerrero MS; Thomas KS; Bouton AH
PLoS One; 2013; 8(6):e65678. PubMed ID: 23762409
[TBL] [Abstract][Full Text] [Related]
47. The mDial formin is required for neutrophil polarization, migration, and activation of the LARG/RhoA/ROCK signaling axis during chemotaxis.
Shi Y; Zhang J; Mullin M; Dong B; Alberts AS; Siminovitch KA
J Immunol; 2009 Mar; 182(6):3837-45. PubMed ID: 19265163
[TBL] [Abstract][Full Text] [Related]
48. Coordinated RhoA signaling at the leading edge and uropod is required for T cell transendothelial migration.
Heasman SJ; Carlin LM; Cox S; Ng T; Ridley AJ
J Cell Biol; 2010 Aug; 190(4):553-63. PubMed ID: 20733052
[TBL] [Abstract][Full Text] [Related]
49. Knockdown of Trio by CRISPR/Cas9 suppresses migration and invasion of cervical cancer cells.
Hou C; Zhuang Z; Deng X; Xu Y; Zhang P; Zhu L
Oncol Rep; 2018 Feb; 39(2):795-801. PubMed ID: 29207149
[TBL] [Abstract][Full Text] [Related]
50. A RhoA and Rnd3 cycle regulates actin reassembly during membrane blebbing.
Aoki K; Maeda F; Nagasako T; Mochizuki Y; Uchida S; Ikenouchi J
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1863-71. PubMed ID: 26976596
[TBL] [Abstract][Full Text] [Related]
51. The microtubule-associated Rho activating factor GEF-H1 interacts with exocyst complex to regulate vesicle traffic.
Pathak R; Delorme-Walker VD; Howell MC; Anselmo AN; White MA; Bokoch GM; Dermardirossian C
Dev Cell; 2012 Aug; 23(2):397-411. PubMed ID: 22898781
[TBL] [Abstract][Full Text] [Related]
52. Thrombin and lysophosphatidic acid receptors utilize distinct rhoGEFs in prostate cancer cells.
Wang Q; Liu M; Kozasa T; Rothstein JD; Sternweis PC; Neubig RR
J Biol Chem; 2004 Jul; 279(28):28831-4. PubMed ID: 15143072
[TBL] [Abstract][Full Text] [Related]
53. NRP-1 interacts with GIPC1 and SYX to activate p38 MAPK signaling and cancer stem cell survival.
Grun D; Adhikary G; Eckert RL
Mol Carcinog; 2019 Apr; 58(4):488-499. PubMed ID: 30456845
[TBL] [Abstract][Full Text] [Related]
54. Extracellular signal-regulated kinase regulates RhoA activation and tumor cell plasticity by inhibiting guanine exchange factor H1 activity.
von Thun A; Preisinger C; Rath O; Schwarz JP; Ward C; Monsefi N; Rodríguez J; Garcia-Munoz A; Birtwistle M; Bienvenut W; Anderson KI; Kolch W; von Kriegsheim A
Mol Cell Biol; 2013 Nov; 33(22):4526-37. PubMed ID: 24043311
[TBL] [Abstract][Full Text] [Related]
55. Modulation of HIV-1 replication by a novel RhoA effector activity.
Wang L; Zhang H; Solski PA; Hart MJ; Der CJ; Su L
J Immunol; 2000 May; 164(10):5369-74. PubMed ID: 10799900
[TBL] [Abstract][Full Text] [Related]
56. Overexpressed hPTTG1 promotes breast cancer cell invasion and metastasis by regulating GEF-H1/RhoA signalling.
Liao YC; Ruan JW; Lua I; Li MH; Chen WL; Wang JR; Kao RH; Chen JH
Oncogene; 2012 Jun; 31(25):3086-97. PubMed ID: 22002306
[TBL] [Abstract][Full Text] [Related]
57. HGAL, a germinal center specific protein, decreases lymphoma cell motility by modulation of the RhoA signaling pathway.
Jiang X; Lu X; McNamara G; Liu X; Cubedo E; Sarosiek KA; Sánchez-García I; Helfman DM; Lossos IS
Blood; 2010 Dec; 116(24):5217-27. PubMed ID: 20844236
[TBL] [Abstract][Full Text] [Related]
58. Leukemia-Associated Rho Guanine Nucleotide Exchange Factor and Ras Homolog Family Member C Play a Role in Glioblastoma Cell Invasion and Resistance.
Ding Z; Dong Z; Yang Y; Fortin Ensign SP; Sabit H; Nakada M; Ruggieri R; Kloss JM; Symons M; Tran NL; Loftus JC
Am J Pathol; 2020 Oct; 190(10):2165-2176. PubMed ID: 32693062
[TBL] [Abstract][Full Text] [Related]
59. Phosphorylation-mediated 14-3-3 protein binding regulates the function of the rho-specific guanine nucleotide exchange factor (RhoGEF) Syx.
Ngok SP; Geyer R; Kourtidis A; Storz P; Anastasiadis PZ
J Biol Chem; 2013 Mar; 288(9):6640-50. PubMed ID: 23335514
[TBL] [Abstract][Full Text] [Related]
60. CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling.
Evelyn CR; Wade SM; Wang Q; Wu M; Iñiguez-Lluhí JA; Merajver SD; Neubig RR
Mol Cancer Ther; 2007 Aug; 6(8):2249-60. PubMed ID: 17699722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
